Despite this and despite the subtle differences in the insulin and GLP-1 curves, mentioned above, these differences did not translate into differences in clinically relevant diabetes measures or diabetes medication use between the groups at any time during the first postoperative year. This evidence concerns the gene GCG and diabetes mellitus.